PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419032
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419032
Ultrasound Needle Guides Market size was valued at USD 276.54 Million in 2022, expanding at a CAGR of 5.9% from 2023 to 2030.
Ultrasound needle guides are medical devices specifically designed to aid healthcare professionals in accurately navigating needles during procedures that involve ultrasound imaging. These guides play a crucial role in enhancing precision, minimizing the risk of complications, and improving the overall effectiveness of various medical procedures such as biopsies, injections, and aspirations. Ultrasound needle guides find their applications in radiology, anesthesia, pain management, and vascular access. Although needle guides have recently been utilized for ultrasound-guided percutaneous renal biopsies, it remains uncertain whether their usage results in reduced post-biopsy complication rates and improved tissue yields.
The market demand for minimally invasive biopsies is anticipated to witness a surge as a result of the increasing preference for these procedures. Minimally invasive techniques, including biopsies, are gaining traction due to their ability to offer advantages such as reduced patient discomfort, shorter recovery periods, and lower risks of complications. Among these techniques, ultrasound-guided biopsies play a pivotal role. In the case of patients considering mediastinal lymphadenopathy, EBUS-TBNA minimally invasive biopsy is performed as a substitute for the traditional Mediastinoscopic lymph node biopsy. This technique is not only minimally invasive and safer, but also boasts a diagnostic accuracy of 97%, making it a potential replacement for most mediastinoscopic procedures, as stated by the thoracic Cancer CARE summit. The market can also benefit from advancements in imaging technologies and ongoing innovations in the design and functionality of ultrasound needle guides. However, it is important to note that limited reimbursement policies may pose a hindrance to the growth of the market.
The Global Ultrasound Needle Guides Market is segmented on the basis of Type, Application, End-User and Region.
The market is divided into two categories based on Type: Disposable Needle Guides and Reusable Needle Guides. Disposable Needle Guides segment dominates the market. Disposable needle guides offer advantages in terms of infection control and convenience. They eliminate the need for reprocessing, reducing the risk of contamination between procedures.
The market is divided into six categories based on Application: Tissue Biopsy, Fluid Aspiration, Nerve Block, Regional Anesthesia, Vascular Access and Others. The market is primarily dominated by the Regional Anesthesia segment. Regional anesthesia procedures are conducted in different healthcare settings, such as hospitals and ambulatory surgery centers. The utilization of ultrasound-guided regional anesthesia may differ across these settings.
The market is divided into four categories based on End-User: Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers and Others. The market is dominated by the Hospitals & Clinics segment. These establishments are known for being at the forefront of embracing cutting-edge medical technologies. In healthcare settings where ultrasound-guided procedures are frequently performed, the implementation of needle guides would be carefully evaluated to enhance precision.
Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to the increasing prevalence of targeted diseases such as breast cancer, cardiovascular disease, arthritis, and others. North America faces a relatively high burden of diseases, which often require ultrasound-guided procedures for diagnosis and intervention. The prevalence of these diseases contributes to the demand for diagnostic and interventional procedures. According to the Center for Disease Control and Prevention, approximately 240,000 cases of breast cancer are diagnosed in women and about 2,100 in men each year in the United States. Additionally, about 42,000 women and 500 men in the U.S. die annually from breast cancer. Europe holds the second-largest market during the forecast period, mainly due to robust research and development activities.
As the healthcare infrastructure continues to expand globally, there is a growing demand for medical devices used in ultrasound-guided interventions. Companies that prioritize research and development are expected to introduce innovative ultrasound needle guide technologies. These companies may focus on advancing needle guidance systems to meet the increasing demand. The competitive landscape of the market could be influenced by partnerships between medical device manufacturers and healthcare institutions. Collaborations of this nature have the potential to facilitate the development of customized solutions or improvements to existing technologies.
In November 2023, Becton, Dickinson and Company (BD) has recently launched SiteRite 9, an advanced vascular access ultrasound system designed to enhance clinician efficiency. The SiteRite 9 all-in-one system aims to assist physicians in efficiently inserting IV lines, central venous catheters, peripherally inserted central catheters (PICCs), and other vascular access devices.
The scope of this report covers the market by its major segments, which include as follows: